Tytuł artykułu
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
Bao-Yuan Decoction (BYD), a widely used traditional Chinese medicine formula, is worth developing into modern dosage forms. To assess the quality of traditional decoction, the commonly used ultra-performance liquid chromatography coupled with diode array and evaporative light scattering detection (UPLC-DAD/ELSD) method was initially applied to develop the analytical methods for the qualitative fingerprints and simultaneous quantitation of multiple marker compounds in BYD. Based on 16 batches of BYD prepared from multiple batches of qualified crude herbs combined randomly, the characteristic fingerprints were generated, with 41 and 19 common peaks detected by DAD and ELSD, respectively. Furthermore, ginsenosides Re, Rg1 and Rb1, calycosin-7-glucoside, calycosin, liquiritin, isoliquiritin apioside, isoliquiritin, glycyrrhizic acid and cinnamic acid were qualified as marker compounds to represent the herbs composing the formula. The characteristic fingerprints and the content ranges of multiple batches of the decoction were obtained, thus providing guidance for the quality control of modern dosage forms. The combination of these qualitative and quantitative methods will be an effective operational measure by which to evaluate and control the quality of BYD from traditional decoction to modern dosage forms.
Słowa kluczowe
Czasopismo
Rocznik
Tom
Strony
87--99
Opis fizyczny
Bibliogr. 12 poz., rys., tab.
Twórcy
autor
- School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, PR China
autor
- School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, PR China
autor
- School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, PR China
autor
- Jing-Jin-Ji Joint Innovation Pharmaceutical (Beijing) Co., Ltd. 100 Balizhuang Road, Beijing 100025, PR China
- Shineway Pharmaceutical Group Ltd., 168 Shiluan Street, Shijiazhuang 051430, PR China
autor
- Jing-Jin-Ji Joint Innovation Pharmaceutical (Beijing) Co., Ltd. 100 Balizhuang Road, Beijing 100025, PR China
- Shineway Pharmaceutical Group Ltd., 168 Shiluan Street, Shijiazhuang 051430, PR China
autor
- School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, PR China
Bibliografia
- 1. Mo, Y. Q.; Tang, J.; Kang, S. P.; Wu, S. J.; Li, B. H.; Wang, T. H. Cardiovasc. Dis. J. Integr. Tradit. Chin. West. Med. 2016, 4, 62–3.
- 2. Qin, Q. J. Pract. Tradit. Chin. Intern. Med. 2007, 21, 60–1.
- 3. Wang, X.; Gao, G; Hu, J. J. Hainan Med. Univ. 2012, 18, 235–7.
- 4. Li, Y. Q.; Zhang, C. H.; Wang, J. N. J. Tradit. Chin. Medicin. Lit. 2014, 32, 15–6.
- 5. Ma, X. L; Guo, X. Y.; Song, Y. L.; Qiao, L. R.; Wang, W. G.; Zhao, M. B.; Tu, P. F.; Jiang, Y. Sci. Rep. 2016, 1–16.
- 6. China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China (I); China Medical Science Press: Beijing, 2015, pp. 8–9.
- 7. China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China (I); China Medical Science Press: Beijing, 2015, pp. 302–3.
- 8. China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China (I); China Medical Science Press: Beijing, 2015; pp. 86–7.
- 9. China Pharmacopoeia Committee. Pharmacopoeia of the People’s Republic of China (I); China Medical Science Press: Beijing, 2015, pp. 136–7.
- 10. Yang, J. J.; Zhao, D. Q.; Zhang, W. Y.; Bai, X. Y.; Wang, S. M. Chin. Tradit. Herb. Drugs 2019, 50, 5778–84.
- 11. Zhou, L. J.; Wang, Z. X.; Long, T. T.; Zhou, X.; Bao, Y. X. Immunol. J. 2017, 33, 469–76.
- 12. Fang, J. Strait Pharm. J. 2017, 29, 28–30.
Uwagi
Opracowanie rekordu ze środków MEiN, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2022-2023).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-c1a80c19-3861-400d-b279-0d85a32c9f30